USD 15.97
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2024 | 236.95 Billion JPY | -9.18% |
2023 | 260.9 Billion JPY | -4.41% |
2022 | 272.94 Billion JPY | 22.39% |
2021 | 223.01 Billion JPY | 18.18% |
2020 | 188.71 Billion JPY | 4.02% |
2019 | 181.41 Billion JPY | -7.16% |
2018 | 195.4 Billion JPY | -4.33% |
2017 | 204.24 Billion JPY | -3.54% |
2016 | 211.74 Billion JPY | 3.46% |
2015 | 204.66 Billion JPY | 0.64% |
2014 | 203.37 Billion JPY | 5.81% |
2013 | 192.21 Billion JPY | 9.59% |
2012 | 175.38 Billion JPY | 5.82% |
2011 | 165.73 Billion JPY | 11.18% |
2010 | 149.07 Billion JPY | 2.57% |
2009 | 145.34 Billion JPY | 1.42% |
2008 | 143.29 Billion JPY | 4.44% |
2007 | 137.2 Billion JPY | -0.83% |
2006 | 138.35 Billion JPY | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 FY | 236.95 Billion JPY | -9.18% |
2024 Q1 | 56.62 Billion JPY | -5.55% |
2024 Q2 | 59.92 Billion JPY | 5.83% |
2024 Q3 | 60.96 Billion JPY | 1.74% |
2024 Q4 | 59.43 Billion JPY | -2.51% |
2023 Q3 | 66.88 Billion JPY | -2.72% |
2023 FY | 260.9 Billion JPY | -4.41% |
2023 Q4 | 59.94 Billion JPY | -10.37% |
2023 Q1 | 65.33 Billion JPY | -12.97% |
2023 Q2 | 68.75 Billion JPY | 5.23% |
2022 Q1 | 63.49 Billion JPY | 2.53% |
2022 Q2 | 70.24 Billion JPY | 10.64% |
2022 FY | 272.94 Billion JPY | 22.39% |
2022 Q3 | 64.14 Billion JPY | -8.69% |
2022 Q4 | 75.06 Billion JPY | 17.03% |
2021 Q1 | 43.9 Billion JPY | -6.32% |
2021 Q4 | 61.92 Billion JPY | -0.95% |
2021 Q3 | 62.52 Billion JPY | 14.38% |
2021 FY | 223.01 Billion JPY | 18.18% |
2021 Q2 | 54.66 Billion JPY | 24.5% |
2020 FY | 188.71 Billion JPY | 4.02% |
2020 Q1 | 46.28 Billion JPY | 0.25% |
2020 Q2 | 47.19 Billion JPY | 1.97% |
2020 Q3 | 48.36 Billion JPY | 2.48% |
2020 Q4 | 46.86 Billion JPY | -3.1% |
2019 Q4 | 46.16 Billion JPY | 1.28% |
2019 Q3 | 45.58 Billion JPY | 1.99% |
2019 FY | 181.41 Billion JPY | -7.16% |
2019 Q1 | 44.97 Billion JPY | 4.04% |
2019 Q2 | 44.69 Billion JPY | -0.62% |
2018 Q2 | 51.73 Billion JPY | -0.83% |
2018 Q4 | 43.22 Billion JPY | -10.45% |
2018 Q1 | 52.16 Billion JPY | 3.53% |
2018 FY | 195.4 Billion JPY | -4.33% |
2018 Q3 | 48.26 Billion JPY | -6.7% |
2017 Q2 | 50.58 Billion JPY | -2.84% |
2017 FY | 204.24 Billion JPY | -3.54% |
2017 Q4 | 50.38 Billion JPY | -1.59% |
2017 Q3 | 51.2 Billion JPY | 1.22% |
2017 Q1 | 52.06 Billion JPY | -0.56% |
2016 Q2 | 53.24 Billion JPY | 0.98% |
2016 Q1 | 52.73 Billion JPY | 4.3% |
2016 Q4 | 52.36 Billion JPY | -1.94% |
2016 Q3 | 53.39 Billion JPY | 0.28% |
2016 FY | 211.74 Billion JPY | 3.46% |
2015 Q1 | 51.2 Billion JPY | 0.8% |
2015 FY | 204.66 Billion JPY | 0.64% |
2015 Q4 | 50.55 Billion JPY | -2.57% |
2015 Q3 | 51.89 Billion JPY | 1.73% |
2015 Q2 | 51.01 Billion JPY | -0.39% |
2014 Q4 | 50.8 Billion JPY | -1.01% |
2014 FY | 203.37 Billion JPY | 5.81% |
2014 Q1 | 50.58 Billion JPY | 6.02% |
2014 Q2 | 50.66 Billion JPY | 0.16% |
2014 Q3 | 51.32 Billion JPY | 1.3% |
2013 Q2 | 47.13 Billion JPY | -4.22% |
2013 Q4 | 47.7 Billion JPY | -0.95% |
2013 FY | 192.21 Billion JPY | 9.59% |
2013 Q1 | 49.2 Billion JPY | 3.27% |
2013 Q3 | 48.16 Billion JPY | 2.2% |
2012 FY | 175.38 Billion JPY | 5.82% |
2012 Q2 | 41.79 Billion JPY | -0.6% |
2012 Q3 | 43.89 Billion JPY | 5.01% |
2012 Q4 | 47.64 Billion JPY | 8.56% |
2012 Q1 | 42.05 Billion JPY | 2.42% |
2011 Q4 | 41.06 Billion JPY | -3.83% |
2011 FY | 165.73 Billion JPY | 11.18% |
2011 Q1 | 41.4 Billion JPY | 14.27% |
2011 Q3 | 42.69 Billion JPY | 5.21% |
2011 Q2 | 40.57 Billion JPY | -1.99% |
2010 Q3 | 38.22 Billion JPY | 2.98% |
2010 Q1 | 37.49 Billion JPY | 7.5% |
2010 Q4 | 36.23 Billion JPY | -5.22% |
2010 FY | 149.07 Billion JPY | 2.57% |
2010 Q2 | 37.12 Billion JPY | -1.01% |
2009 Q4 | 34.88 Billion JPY | -4.25% |
2009 Q3 | 36.42 Billion JPY | -0.32% |
2009 Q2 | 36.54 Billion JPY | 0.0% |
2009 FY | 145.34 Billion JPY | 1.42% |
2008 FY | 143.29 Billion JPY | 4.44% |
2007 FY | 137.2 Billion JPY | -0.83% |
2006 FY | 138.35 Billion JPY | 0.0% |
2005 Q4 | - JPY | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
American Bio Medica Corporation | 913 Thousand USD | -25952802.519% |
Arrayit Corporation | 4.37 Million USD | -5413054.227% |
Atlantic International Corp. | - USD | -Infinity% |
Biocept, Inc. | 25.85 Million USD | -916250.839% |
Bioqual, Inc. | 58.59 Million USD | -404313.999% |
CardioGenics Holdings Inc | - USD | -Infinity% |
DermTech, Inc. | 15.29 Million USD | -1548997.803% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 7.38 Billion USD | -3108.948% |
HTG Molecular Diagnostics, Inc. | 6.36 Million USD | -3721888.873% |
iMD Companies, Inc. | - USD | -Infinity% |
IDenta Corp. | 1.05 Million USD | -22532445.954% |
Interpace Biosciences, Inc. | 40.21 Million USD | -589122.659% |
Integrative Health Technologies, Inc. | 447.49 Thousand USD | -52949738.994% |
InVitro International | 792.62 Thousand USD | -29894125.286% |
Lumos Diagnostics Holdings Limited | 11.13 Million USD | -2128639.556% |
Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
Medical Imaging Corp. | 7.22 Million USD | -3279836.148% |
NovelStem International Corp. | 12 Thousand USD | -1974583233.333% |
Optigenex Inc. | 465.97 Thousand USD | -50850813.149% |
PharmChem, Inc. | 6.01 Million USD | -3940919.922% |
Proteome Sciences plc | 6.4 Million USD | -3701871.239% |
Response Genetics, Inc | 18.04 Million USD | -1313370.067% |
Rennova Health, Inc. | 13.03 Million USD | -1817534.809% |
RushNet, Inc. | 1.78 Million USD | -13253026.608% |
ScreenPro Security Inc. | 1.91 Million USD | -12379066.638% |
Stella Diagnostics Inc. | - USD | -Infinity% |
StageZero Life Sciences Ltd. | 3.79 Million USD | -6243516.729% |
Todos Medical Ltd. | 7.69 Million USD | -3079172.255% |